MAPK3 and liver cancer: Since HPIP has been shown to activate MAPK/ERK1/2 and AKT in breast cancer and liver cancer cells5, 8, we investigated whether activation of MAPK/ERK1/2 and AKT is responsible for HPIP modulation of CRC cell proliferation, migration and EMT.